Skip to content

Eagle Bancorp

US · EGBN #3360 by market cap
28.13 +0.10 +0.34%
Live - 5344 symbols - heartbeat 86s ago · 2026-10-08 10:11
Pre-market 28.05 +0.07%
After-hours 28.03 0.00%
Market cap
857.36M
P/B
0.75
EPS
-4.55
Reader sentiment Are you bullish or bearish on EGBN?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 0.74 In line with history 66th percentile
5-year average 0.78 · #39 of 354 in Banks - Regional
P/E ratio -17.63 Cheap vs history 13th percentile
5-year average -0.95 · forward 15.41
P/S ratio 2.84 In line with history 66th percentile
5-year average 2.90 · forward 3.33 · #105 of 354 in Banks - Regional

Vs. peers Banks - Regional

Company Market cap P/E (TTM) P/B Div yield
Eagle Bancorp (EGBN) 857.36M -17.69 0.75 0.69%
Mizuho Financial (MFG) 129.28B 16.71 1.81 1.64%
HDFC Bank (HDB) 112.04B 15.40 1.33 1.62%
Itau Unibanco (ITUB) 108.62B 11.77 2.50 6.08%
ICICI Bank (IBN) 99.28B 17.90 2.65 0.84%
U.S. Bancorp (USB) 87.55B 11.22 1.44 3.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value32.19 Economic moatNone UncertaintyHigh

Trading 14.5% below Morningstar's fair value estimate.

Fair value

Eagle Bancorp Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 13% discount to our quantitative fair value estimate of $32.19 per share; however, caution is warranted due to this estimate's high uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics bolster our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 133.0%, which lies in the top 20% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are cheap.

Alternatively, the company's lack of growth is potentially concerning. Stagnant revenue and earnings growth indicates a company's challenges in increasing market share and profitability. The firm's revenue 5-year growth of -4.6%, for example, lies in the bottom 20% compared with peers globally. Weak trailing five-year revenue growth is disappointing and could indicate trouble generating future value for shareholders, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.

By Quantitative Equity Report

Quote time 2026-10-08 10:11:00 · For reference only, not investment advice and not tailored to your situation.